Overview and Scope
Hemato oncology testing refers to a diagnostic test that is carried out to detect the presence of symptoms of blood disorders and blood cancers. These tests are used to diagnose anemia, infection, hemophilia, blood-clotting disorders, and leukemia.
Sizing and Forecast
The hemato oncology testing market size has grown rapidly in recent years. It will grow from $3.16 billion in 2023 to $3.59 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing cancer incidence, growing awareness and screening programs, rising healthcare expenditure, increasing adoption of personalized medicine, increasing incidence of blood disorders.
The hemato oncology testing market size is expected to see rapid growth in the next few years. It will grow to $5.98 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to personalized medicine trends, integration of artificial intelligence, rising geriatric population, advancements in genomic research, rising demand for early cancer detection. Major trends in the forecast period include technological advancements in genomic testing, liquid biopsy for non-invasive testing, collaborations and partnerships in the industry, regulatory landscape and standardization, technological advancements.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report
Segmentation & Regional Insights
The hemato oncology testing market covered in this report is segmented –
1) By Product And Services: Assay Kits And Reagents, Services
2) By Cancer Type: Leukemia, Lymphoma, Multiple Myeloma, Other Cancers
3) By Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies
4) By End User: Hospitals, Academic And Research Institutes, Other End Users
North America was the largest region in the hemato oncology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hemato oncology testing market report during the forecast period. The regions covered in the hemato oncology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10075&type=smp
Major Driver Impacting Market Growth
The increasing incidence of hematologic cancer is expected to drive the growth of the hemato oncology testing market going forward. Hematologic cancer refers to a group of cancers that originate in the blood and affect the blood, bone marrow, and lymphatic system and includes diseases such as leukemia, lymphoma, and myeloma. These diseases can be reduced with an early diagnosis which can be achieved using hemato oncology testing. For instance, in 2023, according to the American Cancer Society, a US-based voluntary health organization focusing on eliminating cancer, leukemia is estimated to affect 59,610 American and cause 23,710 deaths. Furthermore, new patients of non-Hodgkin lymphoma are expected to affect 80,550 people in the United States and cause 20,180 deaths. As a result, the increasing prevalence of hematologic cancers is propelling the hemato oncology market forward.
Key Industry Players
Major companies operating in the hemato oncology testing market report are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc., Icon plc, Invivoscribe Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Archerdx Inc., ARUP Laboratories Inc., Asuragen Inc., Adaptive Biotechnologies Corp., Cepheid Inc., EntroGen Inc., CORE Diagnostics Inc., Genoptix Inc., GenPath Diagnostics, NeoGenomics Laboratories Inc., Siemens AG, Sysmex Corporation, Laboratory Corporation of America Holdings, Agilent Technologies, Danaher Corporation, Grifols SA, Exact Sciences Corporation, Guardant Health Corp., Personal Genome Diagnostics Inc., Diaorin SpA, HTG Molecular Diagnostics Inc., Admera Health
The hemato oncology testing market report table of contents includes:
- Executive Summary
- Hemato Oncology Testing Market Characteristics
- Hemato Oncology Testing Market Trends And Strategies
- Hemato Oncology Testing Market – Macro Economic Scenario
- Global Hemato Oncology Testing Market Size and Growth
- Hemato Oncology Testing Market Segmentation
- Hemato Oncology Testing Market Regional And Country Analysis
……………
- Key Mergers And Acquisitions In The Hemato Oncology Testing Market
- Hemato Oncology Testing Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Hemato Oncology Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Hemato Oncology Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
………..
Table 75: F. Hoffmann-La Roche Ltd. Financial Performance
Table 76: Abbott Laboratories Financial Performance
Table 77: Thermo Fisher Scientific Inc. Financial Performance
Table 78: Illumina Inc. Financial Performance
Table 79: Icon plc Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/digital-ad-spending-market-growth/
https://topprnews.com/distributed-natural-gas-fueled-generation-market-opportunities/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
